期刊
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION
卷 8, 期 12, 页码 891-897出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jash.2014.09.015
关键词
Hypertension; reimbursement claims; white coat hypertension
资金
- National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) [P01-HL047540, P01-HL047540-19S1]
The US Centers for Medicaid and Medicare Services reimburses ambulatory blood pressure monitoring (ABPM) for suspected white coat hypertension. We estimated ABPM use between 2007 and 2010 among a 5% random sample of Medicare beneficiaries (>= 65 years). In 2007, 2008, 2009, and 2010, the percentage of beneficiaries with ABPM claims was 0.10%, 0.11%, 0.10%, and 0.09%, respectively. A prior diagnosis of hypertension was more common among those with versus without an ABPM claim (77.7% vs. 47.0%). Among hypertensive beneficiaries, 95.2% of those with an ABPM claim were taking antihypertensive medication. Age 75-84 versus 65-74 years, having coronary heart disease, having chronic kidney disease, having multiple prior hypertension diagnoses, and having filled multiple classes of antihypertensive medication were associated with an increased odds for an ABPM claim among hypertensive beneficiaries. ABPM use was very low among Medicare beneficiaries and was not primarily used for diagnosing white coat hypertension in untreated individuals. (C) 2014 American Society of Hypertension. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据